Provided is a novel method for treating cancer using an HSP90 inhibitor which demonstrates a markedly superior anti-tumor effect and has less side effects. An antitumor agent which is characterized in that an azabicyclo compound represented by general formula (1) or a salt thereof is administered in combination with another antitumor agent.